Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans

Citation
M. Spitzer et al., Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans, NEUROPHARM, 41(2), 2001, pp. 263-271
Citations number
38
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROPHARMACOLOGY
ISSN journal
00283908 → ACNP
Volume
41
Issue
2
Year of publication
2001
Pages
263 - 271
Database
ISI
SICI code
0028-3908(200108)41:2<263:ECABAE>2.0.ZU;2-N
Abstract
In a randomised double-blind trial the subjective, neuropsychological and b rain activation effects of the two enantiomers of the MDMA (ecstasy-) like drug N-ethyl-3,4-methylenedioxyamphetamine (NIDE) were studied in five norm al subjects using functional magnetic resonance imaging (fMRI). (S)-MDE pro duced elevated mood, impairments in conceptually driven cognition and marke d right frontal activation. In contrast, (R)-MDE produced increased depress ion, enhanced visual feature processing, and activation of visual cortical and left frontal areas. Plasma concentrations were higher for the (R)-enant iomer. The so-called entactogenic effects of MDE are likely to be caused by the (S)-enantiomer, whereas (R)-MDE appears to be responsible for neurotox ic effects. (C) 2001 Elsevier Science Ltd. All rights reserved.